Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pulikkottil O. Esmy"'
Autor:
Neerja Bhatla, Richard Muwonge, Sylla G. Malvi, Smita Joshi, Usha Rani Reddy Poli, Eric Lucas, Pulikkottil O. Esmy, Yogesh Verma, Anand Shah, Eric Zomawia, Sharmila Pimple, Kasturi Jayant, Sanjay Hingmire, Aruna Chiwate, Shachi Vashist, Gauravi Mishra, Radhika Jadhav, Maqsood Siddiqi, Devasena Anantharaman, Gitika Panicker, Julia Butt, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Rintu Varghese, Purnima Kartha, M. Radhakrishna Pillai, Tim Waterboer, Martin Müller, Peter Sehr, Elizabeth R. Unger, Rengaswamy Sankaranarayanan, Partha Basu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTLong-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an Indian multi-centric study allowed us to compare antibody responses between the younge
Externí odkaz:
https://doaj.org/article/04a82d9a420242adaf6971141ec56cbe
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
Autor:
Smita, Joshi, Devasena, Anantharaman, Richard, Muwonge, Neerja, Bhatla, Gitika, Panicker, Julia, Butt, Usha, Rani Reddy Poli, Sylla G, Malvi, Pulikkottil O, Esmy, Eric, Lucas, Yogesh, Verma, Anand, Shah, Eric, Zomawia, Sharmila, Pimple, Kasturi, Jayant, Sanjay, Hingmire, Aruna, Chiwate, Uma, Divate, Shachi, Vashist, Gauravi, Mishra, Radhika, Jadhav, Maqsood, Siddiqi, Subha, Sankaran, Thiraviam, Pillai Rameshwari Ammal Kannan, Purnima, Kartha, Surendra S, Shastri, Catherine, Sauvaget, M, Radhakrishna Pillai, Tim, Waterboer, Martin, Müller, Peter, Sehr, Elizabeth R, Unger, Rengaswamy, Sankaranarayanan, Partha, Basu
Publikováno v:
Vaccine. 41:236-245
The recent World Health Organization recommendation supporting single-dose of HPV vaccine will significantly reduce programmatic cost, mitigate the supply shortage, and simplify logistics, thus allowing more low- and middle-income countries to introd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030ffaf9620373d89d5e9cc3cde20e49
https://doi.org/10.1016/j.vaccine.2022.11.044
https://doi.org/10.1016/j.vaccine.2022.11.044
Autor:
Tarik, Gheit, Richard, Muwonge, Eric, Lucas, Luisa, Galati, Devasena, Anantharaman, Sandrine, McKay-Chopin, Sylla G, Malvi, Kasturi, Jayant, Smita, Joshi, Pulikkottil O, Esmy, M Radhakrishna, Pillai, Partha, Basu, Rengaswamy, Sankaranarayanan, Massimo, Tommasino
Publikováno v:
Oral Oncology. 136:106244
Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. Although the efficacy of the HPV vaccine in preventing the development of cervical pre-malignant lesions has been well demonstrated, the efficacy of the H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c66e34eb4bd7a0b41591712ad5ce711
https://doi.org/10.1016/j.oraloncology.2022.106244
https://doi.org/10.1016/j.oraloncology.2022.106244